Effects Of Strategy Training And PNF On Balance, Gait, And Independence In Parkinson's Disease

March 16, 2026 updated by: Riphah International University

Effects of Strategy Training Versus Proprioceptive Neuromuscular Facilitation Technique on Balance, Gait, and Functional Independence in Patients With Parkinson's Disease

This randomized controlled trial aims to compare the effects of Strategy Training and Proprioceptive Neuromuscular Facilitation (PNF) on balance, gait, and functional independence in patients with Parkinson's disease. Parkinson's disease leads to impaired motor function, reduced balance, and decreased independence. Physiotherapy interventions such as strategy-based training and PNF may help improve mobility and functional performance. Participants will be randomly assigned to two groups: one receiving Strategy Training and the other receiving PNF intervention. Outcome measures including balance tests, gait assessment, and functional independence scales will be evaluated before and after treatment. The study aims to determine which intervention is more effective in improving functional outcomes in Parkinson's disease patients.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Global hospital and dialysis center Lahore
        • Contact:
      • Lahore, Punjab Province, Pakistan, 54000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:Diagnosed with Parkinson's Disease. Aged 40 to 80 years UPDRS level should be 2 and score will be 20-60 Able to walk independently or with minimal assistance Cognitively able to follow instructions

Exclusion Criteria:Severe comorbidities (e.g., cardiovascular, neurological) Recent surgery (within the last 6 months) Recent changes in Parkinson's medication Currently participating in other clinical trials Uncontrolled symptoms of Parkinson's Disease (e.g., severe tremors) Contraindications to rehabilitation treatment Resting systolic blood pressure>160mmHgor<100mmHg and resting diastolic pressure>100mmHg<6mmHg

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A: PNF Technique
Participants will undergo PNF techniques targeting the muscles involved in balance and gait. This may include diagonal patterns, facilitation techniques, and proprioceptive neuromuscular facilitation holds.
Other: PNF Technique
Participants will undergo PNF techniques targeting the muscles involved in balance and gait. This may include diagonal patterns, facilitation techniques, and proprioceptive neuromuscular facilitation holds.
Experimental: Group B: Strategy training
Strategy Training Group Participants will receive training in specific cognitive strategies to improve balance and gait. This will include visual cues, verbal instructions, and mental rehearsal techniques.
Other: Strategy Training
Strategy Training Group Participants will receive training in specific cognitive strategies to improve balance and gait. This will include visual cues, verbal instructions, and mental rehearsal techniques.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
10-Meter Walk Test (10MWT)
Time Frame: 6 weeks
The 10-Meter Walk Test (10MWT) is an effective instrument that is applied to determine the walking speed and functional mobility in different populations.
6 weeks
Tandem Stance Test
Time Frame: 6 weeks
Tandem Stance Test is one of the essential clinical tests of balance and postural stability particularly among older adults. It involves getting a person to stand on their heels to toes and this is used to determine people who are at risk of falling.
6 weeks
Pastor Test (Shoulder Tug)
Time Frame: 6 weeks
Pastor Test (Shoulder Tug test) is a test used to determine the shoulder stability (especially the anterior shoulder instability). In the test, the examiner pulls the patient using his arm as he keeps the shoulder constant to reveal too much movement or pain.
6 weeks
30 sec Chair Test
Time Frame: 6 weeks
30 sec Chair Test; A popular test for assessing lower body strength, balance, and functional mobility especially in older adults is the chair test. It gauges a person's capacity to carry out daily tasks on their own by timing how long it takes them to get up from a sitting position and sit down again.
6 weeks
Retropulsion Test
Time Frame: 6 weeks
Retropulsion Test is a clinical examination, which is mainly applied to determine the postural stability and balance in a person, particularly the people with Parkinson disease. In this test, the examiner smoothly pulls the shoulders of the patient in the standing position where the patient stands in a relaxed position, and the examiner sees whether the patient can balance or not.
6 weeks
Unified Parkinson's Disease Rating Scale (UPDRS)
Time Frame: 6 weeks
Unified Parkinson Disease Rating Scale (UPDRS) as one of the important assessment instruments in the study of Parkinson disease and its clinical application. (UPDRS) scale is a comprehensive tool, employed to assess treatment issues related to the treatment of the Parkinson disease, the daily life activities as well as the motor and non-motor symptoms.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Arnab Altaf, MS-PT, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

March 16, 2026

First Submitted That Met QC Criteria

March 16, 2026

First Posted (Actual)

March 20, 2026

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 16, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/RCR&AHS/B43-098

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease (PD)

Clinical Trials on PNF Technique

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe